ALLO vs RL · rev $22.0K vs P/E 24, rev $8.11B
Allogene Therapeutics Inc (ALLO) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
ALLO currently screens at market cap $258.1M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the ALLO and RL stock pages for the full models.
Not investment advice.